Etcembly featured in BIA TechBio 2023 report
Etcembly are showcased as one of the companies driving the UK's AI revolution. https://techbio.org.uk/wp-content/uploads/2023/10/TechBio-...
top of page
![E3353_06 [ALT4ax].png](https://static.wixstatic.com/media/73af19_3c2aa92876234a68b46bead64acb0ce5~mv2.png/v1/fill/w_48,h_47,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/73af19_3c2aa92876234a68b46bead64acb0ce5~mv2.png)
- Dec 2, 2023
Could AI cure cancer?
Marc Emmer at Inc. highlights how our approach could accelerate the development of new imnmunotherapies. https://www.inc.com/marc-emmer/...
38 views
- Dec 2, 2023
Supporting the next generation in biotech
Discover how we're enabling our former intern Gusztav Milotay to pursue a PhD at the University of Oxford.
28 views
- Dec 2, 2023
Etcembly aims at cancer with AI-driven, rapid TCR engineering technology
Caroline Richards at BioWorld explores how our AI-driven approach is enabling TCR discovery and optimisation at unprecedented scale and...
37 views
- Dec 2, 2023
Interview with CEO Michelle Teng in Inside Precision Medicine
Etcembly co-founder Michelle Teng talks to Helen Albert about her journey in science and how we're building the next generation of...
35 views
bottom of page